Journal of the American Medical Association · 1926 · 21 citations · 3 references
MedicineDermatologyInfectious DiseasesEpidemiologyInfectious Disease EpidemiologyRheumatologySkin InfectionsVascular Skin LesionsAbrasionsErysipelas Skin LesionsPeripheral Vascular InjuryRetrospective Case StudySeasonal Distribution Analysis
Accumulated evidence pointing to the existence of a specific type ofStreptococcus hemolyticusas the etiologic agent in erysipelas suggested that a serum made with this specific organism would be beneficial in the treatment of erysipelas. During the last year, an antiserum against this type of streptococcus has been produced and has been used in the treatment of cases of erysipelas. The results of the use of this serum are described in this paper. The etiology of erysipelas was first studied by Fehleisen,1in 1883, and since that time active investigations have been conducted on the biology ofStreptococcus hemolyticus, particularly by means of serologic methods. Type specificity within the large group of hemolytic streptococci has been a subject of intense study during the last thirty years. As a result of such studies, the causation of scarlet fever appears to have been definitely settled, and measures have subsequently developed
3